(Q41700785)

7 October 2017

title

Dose-dependent cytotoxic and mutagenic effects of antineoplastic alkylating agents on human lymphoblastoid cells (English)

1 reference

7 October 2017

Sanderson BJ

1

1 reference

7 October 2017

Johnson KJ

series ordinal

2

1 reference

7 October 2017

Henner WD

series ordinal

3

1 reference

7 October 2017

publication date

1 January 1991

1 reference

Environmental and Molecular Mutagenesis

7 October 2017

published in

1 reference

7 October 2017

volume

17

1 reference

7 October 2017

issue

4

1 reference

7 October 2017

page(s)

238-243

1 reference

Review of the molecular characteristics of gene mutations of the germline and somatic cells of the human

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

Mutation of human lymphoblasts exposed to low concentrations of chemical mutagens for long periods of time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

Elevated frequencies of 6-thioguanine-resistant lymphocytes in multiple sclerosis patients treated with cyclophosphamide: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

7 January 2021

Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU)

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

7 January 2021

https://api.crossref.org/works/10.1002%2FEM.2850170404

1 reference

7 January 2021

Chromosome damage during nitrogen mustard therapy. A case report

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

7 January 2021

The induction of aneuploidy by nitrogen mustard in a human lymphoblastoid cell line

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

7 January 2021

Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

7 January 2021

Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma. A new complication of cyclophosphamide, methotrexate, and 5-fluorouracil therapy

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

7 January 2021

Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

7 January 2021

Acute leukemia following intensive therapy for small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

7 January 2021

Chlorambucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

7 January 2021

Thioguanine-resistant mutations induced by cytotoxic drugs in lymphocytes of patients with connective tissue diseases.

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

7 January 2021

Transplacental teratogenesis and mutagenesis in mouse fetuses treated with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

7 January 2021

Results of tests for micronuclei and chromosomal aberrations in mouse bone marrow cells with the human carcinogens 4-aminobiphenyl, treosulphan, and melphalan

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

7 January 2021

Risk of second cancers after treatment for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

7 January 2021

Second acute leukemia and other malignancies following treatment for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850170404

7 January 2021

Identifiers

DOI

10.1002/EM.2850170404

1 reference

7 October 2017

1 reference